Search results
Amgen Inc (AMGN) Q1 2024 Earnings: Aligns with EPS Projections Amid Revenue Growth and Challenges
GuruFocus.com via Yahoo Finance· 7 days agoDividends: Paid a dividend of $2.25 per share, representing a 6% increase from the previous year. On May 2, 2024, Amgen Inc (NASDAQ:AMGN) disclosed its financial results for ...
Amgen Is 'Very Encouraged' With Its Obesity Drug. But Can It Take On Novo, Lilly Duopoly?
Investor's Business Daily· 6 days agoAdjusted earnings slipped 1% to $3.96 per share, coming in above expectations for $3.88, according...
Big Pharma Has Captured Osteoporosis
Mercola· 6 days agoThe sales funnel concept is crucial to understanding the modern medical industry. The second funnel involves framing preventative medicine as screening individuals for potential health risks ...
Neurocrine Biosciences Presents CAHtalyst™ Adult Study Baseline Characteristics and Data on Impact...
WRBL Columbus· 1 hour agoThe CAHtalyst Adult study baseline data demonstrate the potential long-term consequences of current CAH treatments, with many patients in young adulthood experiencing disorders ...
This Gave Me Osteoporosis At 32 & Here's What I Wish People Knew
MindBodyGreen· 5 days agoIn this mindbodygreen series, we're giving individuals with invisible illnesses a platform to share...
Over 50 and Can't Lose Weight? What to Know About Sarcopenia + How to Fix It With Protein
Woman's World via Yahoo News· 6 days agoSnack Top 1 small bowl of Greek yogurt with 1⁄2 cup of fruit or any variety protein bar with at...
For Older Adults, Breaking a Hip Can Be Deadlier Than Cancer
Verywell Health via Yahoo News· 6 days agoWhat Might Predispose Someone to Poor...fall would lead to worsening outcomes,” Bawer said, listing...
Health Benefits of Vitamin K2 (Menaquinone)
Health via Yahoo News· 5 hours agoVitamin K2 (menaquinone) is made in the gut and found in certain foods. It’s also available as a supplement. The K vitamin has several health benefits.
Amgen Is 'Very Encouraged' With Its Obesity Study; Shares Rocket 13%
Investor's Business Daily· 7 days agoThe company didn't provide any numbers from its study of MariTide in adults with obesity. This puts Amgen on track to potentially rival blockbuster weight-loss drugs from Eli Lilly (LLY) and ...
Rani Therapeutics Q1 2024 Earnings: Financial Performance and Strategic Updates
GuruFocus.com via Yahoo Finance· 2 days agoAdditionally, the company is gearing up for the initiation of a Phase 2 trial for RT-102, aimed at...
